AGIOS PHARMACEUTICALS INC. - COMMON STOCK

Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia

04 Aug 2025 13:01:00 By Nasdaq GlobeNewswire

Agios Reports Second Quarter 2025 Financial Results and Provides Business Update

31 Jul 2025 03:30:23 By Nasdaq GlobeNewswire

Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET

14 Jul 2025 04:00:00 By Nasdaq GlobeNewswire

Agios Appoints Dr. Jay Backstrom to Board of Directors

08 Jul 2025 04:00:00 By Nasdaq GlobeNewswire

Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025

28 May 2025 04:00:00 By Nasdaq GlobeNewswire

Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress

14 May 2025 07:00:00 By Nasdaq GlobeNewswire

Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025

09 May 2025 04:00:00 By Nasdaq GlobeNewswire

Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025

02 May 2025 04:00:00 By Nasdaq GlobeNewswire

Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights

01 May 2025 03:30:00 By Nasdaq GlobeNewswire

Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025

17 Apr 2025 04:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

09 Apr 2025 06:57:01 By NetDania Notify

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

08 Apr 2025 10:50:06 By NetDania Notify

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

07 Apr 2025 06:45:27 By NetDania Notify

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

04 Apr 2025 06:58:04 By NetDania Notify

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

01 Apr 2025 10:49:16 By NetDania Notify

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer

05 Mar 2025 14:52:45 By Nasdaq GlobeNewswire

Agios to Present at Upcoming Investor Conferences

04 Mar 2025 04:00:00 By Nasdaq GlobeNewswire

Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025

20 Feb 2025 04:00:00 By Nasdaq GlobeNewswire

Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

13 Feb 2025 03:31:00 By Nasdaq GlobeNewswire

Agios’ Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint

13 Feb 2025 03:30:00 By Nasdaq GlobeNewswire